Combination of gemcitabine and cetuximab in patients with advanced cholangiocarcinoma: a phase II study of the Belgian Group of Digestive Oncology von Borbath, I., Ceratti, A., Verslype, C., Demols, A., Delaunoit, T., Laurent, S., Deleporte, A., Vergauwe, P., Van Maanen, A., Sempoux, C., Van Cutsem, E., Van Laethem, J.L.

Volltext

Boerhaave's syndrome : successful conservative treatment in two patients von Truyens, M., Hufkens, E., Van Geluwe, B., Vergauwe, P., Van Moerkercke, W.

Volltext

Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer.... von Köhne, C.-H., De Greve, J., Hartmann, J. T., Lang, I., Vergauwe, P., Becker, K., Braumann, D., Joosens, E., Müller, L., Janssens, J., Bokemeyer, C., Reimer, P., Link, H., Späth-Schwalbe, E., Wilke, H.-J., Bleiberg, H., Van Den Brande, J., Debois, M., Bethe, U., Van Cutsem, E.

Volltext

A two arm phase II study of FOLFIRI in combination with standard or escalating dose of cetuximab as first line treatment for metastatic colorectal cancer: Everest 2 final results von Chiritescu, G., Dumon, K., Mercadé, T. Macarulla, Lang, I., Vivas, C. Santos, Papai, Z., Janssens, J., Hendrickx, K., Pracht, M., Van den Eynde, M., Taïeb, J., Moons, V., Geboes, K., Van Laethem, J., Greil, R., Cervantes, A., Vergauwe, P., Ferrante, M., Vanderstraeten, E., Fridrik, M., Wöll, E., Limón, M., Rivera, F., Sagaert, X., Tejpar, S., Van Cutsem, E.

Volltext

Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's Disease von Baert, Filip, Moortgat, Liesbeth, Van Assche, Gert, Caenepeel, Philip, Vergauwe, Philippe, De Vos, Martine, Stokkers, Pieter, Hommes, Daniel, Rutgeerts, Paul, Vermeire, Severine, D'Haens, Geert

Volltext

Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, control... von Eng, Cathy, Kim, Tae Won, Bendell, Johanna, Argilés, Guillem, Tebbutt, Niall C, Di Bartolomeo, Maria, Falcone, Alfredo, Fakih, Marwan, Kozloff, Mark, Segal, Neil H, Sobrero, Alberto, Yan, Yibing, Chang, Ilsung, Uyei, Anne, Roberts, Louise, Ciardiello, Fortunato, Ahn, JB, Asselah, J, Badarinath, S, Baijal, S, Begbie, S, Berry, S, Canon, JL, Carbone, RG, Cervantes, A, Cha, YJ, Chang, K, Chaudhry, A, Chmielowska, E, Cho, SH, Chu, D, Couture, F, Cultrera, J, Cunningham, D, Van Cutsem, E, Cuyle, PJ, Davies, J, Dowden, S, Dvorkin, M, Ganju, V, Garcia, RV, Kerr, R, Kim, TY, King, K, Kortmansky, J, Kozloff, M, Lam, KO, Lee, J, Lee, AS, Lesperance, B, Luppi, G, Ma, B, Maiello, E, Mandanas, R, Marshall, J, Marx, G, Mullamitha, S, Nechaeva, M, Park, JO, Pavlakis, N, Ponce, CG, Potemski, P, Raouf, S, Reeves, J, Segal, N, Siena, S, Smolin, A, Streb, JO, Strickland, A, Szutowicz-Zielinska, E, Tabernero, JM, Tan, B, Valera, JS, Van den Eynde, M, Vergauwe, P, Vickers, M, Womack, M, Wroblewska, M, Young, R

Volltext

PD-0568 PHASE II STUDY OF NEO ADJUVANT TREATMENT WITH AVASTIN, XELODA AND ELOXATIN IN RECTAL CANCER (AXE BEAM) von Debucquoy, A, Verstraete, M, Chiritescu, G, Dumon, K, Vergauwe, P, Machiels, J.P, Penninckx, F, Sagaert, X, Van Cutsem, E, Haustermans, K

Volltext

Internal jugular vein thrombosis after ovarian stimulation von BELAEN, B, GEERINCKX, K, VERGAUWE, P, THYS, J

Volltext

Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial von Cornely, Oliver A, Prof, Crook, Derrick W, Prof, Esposito, Roberto, Prof, Poirier, André, MD, Somero, Michael S, MD, Weiss, Karl, Prof, Sears, Pamela, PhD, Gorbach, Sherwood, Prof

Volltext

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised control... von Nordlinger, Bernard, Prof, Sorbye, Halfdan, MD, Glimelius, Bengt, Prof, Poston, Graeme J, MD, Schlag, Peter M, Prof, Rougier, Philippe, Prof, Bechstein, Wolf O, Prof, Primrose, John N, Prof, Walpole, Euan T, MD, Finch-Jones, Meg, MD, Jaeck, Daniel, MD, Mirza, Darius, MD, Parks, Rowan W, MD, Collette, Laurence, PhD, Praet, Michel, ScD, Bethe, Ullrich, MD, Van Cutsem, Eric, MD, Scheithauer, Werner, MD, Gruenberger, Thomas, Prof

Volltext

A phase II randomized study of combined infusional leucovorin sodium and 5- FU versus the leucovorin calcium followed by 5-FU both in combination with irinotecan or oxaliplatin in... von Bleiberg, H, Vandebroek, A, Deleu, I, Vergauwe, P, Rezaei Kalantari, H, D'Haens, G, Paesmans, M, Peeters, M, Efira, A, Humblet, Y

Volltext

LBA2 Interim efficacy analysis of REGINA, a phase II trial of neoadjuvant regorafenib (Rego), nivolumab (Nivo), and short-course radiotherapy (SCRT) in stage II-III rectal cancer (... von Sclafani, F., Bregni, G., Assaf, I., Puleo, F., Vergauwe, P., Prenen, H., Diaz, M., Gokburun, Y., Sanchez, A. Veron, Anthoine, G., Moretti, L., Gomez Galdon, M., Liberale, G., Martinive, P., Geboes, K., Carrasco, J., van den Eynde, M., Laethem, J-L. van, Buyse, M.E., Hendlisz, A.

Volltext

Fidaxomicin Versus Vancomycin for Clostridium difficile Infection: Meta-analysis of Pivotal Randomized Controlled Trials von Crook, Derrick W., Walker, A. Sarah, Kean, Yin, Weiss, Karl, Cornely, Oliver A., Miller, Mark A., Esposito, Roberto, Louie, Thomas J., Stoesser, Nicole E., Young, Bernadette C., Angus, Brian J., Gorbach, Sherwood L., Peto, Timothy E. A.

Volltext

P-276 Sex and regorafenib toxicity in refractory colorectal cancer: A safety analysis of the RegARd-C trial von Vandeputte, C., Bregni, G., Paraskevas, G., Guiot, T., Kehagias, P., Deleporte, A., Geboes, K., Delaunoit, T., Demolin, G., Peeters, M., D'Hondt, L., Janssens, J., Carrasco, J., Holbrechts, S., Goeminne, J., Vergauwe, P., Van Laethem, J., Flamen, P., Hendlisz, A., Sclafani, F.

Volltext

Boerhaave's syndrome : successful conservative treatment in two patients von Truyens, M, Hufkens, E, Van Geluwe, B, Vergauwe, P, Van Moerkercke, W

Volltext

505TiP REGINA: A phase II trial of neoadjuvant regorafenib (rego) in combination with nivolumab (nivo) and short-course radiotherapy (SCRT) in intermediate-risk, stage II-III recta... von Bregni, G., Senti, C., Reina, E. Acedo, Gkolfakis, P., Moretti, L., Veron, A., Demetter, P., Liberale, G., Carrasco, J., Geboes, K., Gokburun, Y., Peeters, M., Van den Eynde, M., Laethem, J-L. van, Vergauwe, P., Buyse, M.E., Deleporte, A., Hendlisz, A., Sclafani, F.

Volltext

Azathioprine induced colitis : a case report and review of the literature von BOSSUYT, P, VERGAUWE, P, INDERADJAJA, N, VERMEIRE, S

Volltext

449P Randomized phase II study comparing pathological responses of resected colorectal cancer metastases (CRCM) after bevacizumab (BEV) with FOLFOX or FOLFIRI (BEV-ONCO trial) von Baldin, P., Beniuga, G., Jouret-Mourin, A., Demolin, G., Roland, S., D'Hondt, L.A., Vergauwe, P., Vandaele, D., Mailleux, M., Sinapi, I., De Cuyper, A., Bletard, N., Massart, B., Delos, M., Castella, M-L., van Maanen, A., Carrasco, J., van den Eynde, M.

Volltext

O-015A two arm phase II study of FOLFIRI in combination with standard or escalating dose of cetuximab as first line treatment for metastatic colorectal cancer: Everest 2 final resu... von Chiritescu, G, Dumon, K, Mercadé, T Macarulla, Lang, I, Vivas, C Santos, Papai, Z, Janssens, J, Hendrickx, K, Pracht, M, Van den Eynde, M, Taïeb, J, Moons, V, Geboes, K, Van Laethem, J, Greil, R, Cervantes, A, Vergauwe, P, Ferrante, M, Vanderstraeten, E, Fridrik, M, Wöll, E, Limón, M, Rivera, F, Sagaert, X, Tejpar, S, Van Cutsem, E

Volltext

AVAPLUS: Impact of geriatric assessment on first-line treatment duration (TD) and progression free survival (PFS) in mCRC patients ≥ 70 years von Decoster, L., Kenis, C., Naessens, B., Houbiers, G., De Man, M., Lambecht, G., Monsaert, E., Moons, V., Vergauwe, P., Prenen, H., Van Cutsem, E., Beutels, E., Frijns, D., Wildiers, H.

Volltext